David Brunel

David Brunel possesses extensive experience in leadership roles across various organizations. Currently serving as a Board Member at Velocity Sciences and holding Chairman positions at AmideBio, KromaTiD™ Inc., and Anark Corporation, Brunel has significantly contributed to sectors such as biotechnology, manufacturing software, and molecular diagnostics. David's previous positions include Chairman of Xyleme, Inc. and Biodesix, Inc., as well as leadership roles at UCOPIA and eMotion, Inc. Brunel's academic background includes a Master’s degree in International Studies from the University of Denver and a Bachelor's degree in Chemistry from Colorado State University.